Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3615)
All Articles published online
|
Jan 14, 2013 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | El Awady MK, Bader El Din NG, Tabll A, El Hosary Y, Abdel Aziz AO, El Khayat H, Salama M, Abdelhafez TH. IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients. World J Gastroenterol 2013; 19(2): 290-298 [PMID: 23345953 DOI: 10.3748/wjg.v19.i2.290] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i2/290.htm |
| Number | Citing Articles |
| 1 |
Ghada M. Salum, Reham M. Dawood, Mai Abd el-Meguid, Noha E. Ibrahim, Ashraf O. Abdel Aziz, Mostafa K. El Awady. Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients. Genes & Diseases 2020; 7(3): 392 doi: 10.1016/j.gendis.2019.05.004
|
| 2 |
Mohamed Abd El-Fattah. Predictive power of Interleukin–28B gene variants for outcome of Hepatitis C Virus genotype 4 in Egyptians: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2021; 45(2): 101480 doi: 10.1016/j.clinre.2020.06.006
|
| 3 |
Marwa K. Ibrahim, Ghada Maher Salum, Noha G. Bader El Din, Reham M. Dawood, Ahmed Barakat, Ahmed Khairy, Mostafa K. El Awady, Golo Ahlenstiel. Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis. PLOS ONE 2016; 11(5): e0154512 doi: 10.1371/journal.pone.0154512
|
| 4 |
Hend Ibrahim Shousha, Abubakr Hussein Awad, Dalia Abdelhamid Omran, Mayada Mohamed Elnegouly, Mahasen Mabrouk. Data Mining and Machine Learning Algorithms Using <i>IL28B</i> Genotype and Biochemical Markers Best Predicted Advanced Liver Fibrosis in Chronic Hepatitis C. Japanese Journal of Infectious Diseases 2018; 71(1): 51 doi: 10.7883/yoken.JJID.2017.089
|
| 5 |
Wael Abdel-Razek, Imam Waked. Optimal Management of HCV Genotype 4. Current Hepatology Reports 2014; 13(4): 286 doi: 10.1007/s11901-014-0243-5
|
| 6 |
Noha Gamal Bader El Din, Ghada M. Salum, Mohamed A. Anany, Marwa Khalil Ibrahim, Reham Mohamed Dawood, Naglaa Zayed, Yasmine S. El Abd, Reem El-Shenawy, Mostafa K. El Awady. Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients. Journal of Interferon & Cytokine Research 2015; 35(8): 641 doi: 10.1089/jir.2014.0137
|
| 7 |
Yulan Wang, Tianxing Deng, Li Zeng, Weiqing Chen. Efficacy and safety of radiofrequency ablation and transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: A meta‐analysis. Hepatology Research 2016; 46(1): 58 doi: 10.1111/hepr.12568
|
| 8 |
Imam Waked, Waheed Doss, Manal Hamdy El-Sayed, Chris Estes, Homie Razavi, Gamal Shiha, Ayman Yosry, Gamal Esmat. The current and future disease burden of chronic hepatitis C virus infection in Egypt. Arab Journal of Gastroenterology 2014; 15(2): 45 doi: 10.1016/j.ajg.2014.04.003
|
| 9 |
Rehab M. Ateya, Samir A. Afifi, Nagla Abd Al Monem, Amira S. Al-Karamany, Ahmed A. Bessar, Fatma Rageh, Samar S. Ahmed, Dalia Ghareeb. Impact of IL-28B gene polymorphism on chronic hepatitis-C patients progression with diabetes and non-diabetes. Egyptian Journal of Medical Human Genetics 2022; 23(1) doi: 10.1186/s43042-022-00239-3
|
| 10 |
Noha G. Bader El Din, Mohamed A. Anany, Reham M. Dawood, Marwa K. Ibrahim, Reem El-Shenawy, Yasmin S. El Abd, Mostafa K. El Awady. Impact ofOAS1Exon 7 rs10774671 Genetic Variation on Liver Fibrosis Progression in Egyptian HCV Genotype 4 Patients. Viral Immunology 2015; 28(9): 509 doi: 10.1089/vim.2015.0041
|
| 11 |
Tawhida Y Abdel-Ghaffar, Mostafa M Sira, Suzan El Naghi. Hepatitis C genotype 4: The past, present, and future. World Journal of Hepatology 2015; 7(28): 2792-2810 doi: 10.4254/wjh.v7.i28.2792
|
| 12 |
Á. Rojas, J. A. del Campo, M. Maraver, R. Aparcero, M. García‐Valdecasas, M. Diago, I. Carmona, R. J. Andrade, R. Solà, M. Romero‐Gómez. Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro. Journal of Viral Hepatitis 2014; 21(1): 19 doi: 10.1111/jvh.12209
|
| 13 |
Gamal Eldeen Esmat, Wafa Al Akel, Rasha Ahmed Abdel Aziz, Ahmed Al Sayed Taha, Dina Sabry, Laila A. Rashed, Aya Mostafa, Amany Y. El Kazaz, Sahar H. Ahmed. Hepatitis C Viral Kinetic Changes in a Retrospective Cohort Study of Chronic Hepatitis C Virus Egyptian Patients on Pegylated Interferon and Ribavirin Therapy. Journal of Interferon & Cytokine Research 2016; 36(3): 149 doi: 10.1089/jir.2015.0099
|
| 14 |
Abdel-Rahman N. Zekri, Dina Abdullah, Ahmed Osman, Mahmoud N. El-Rouby, Naglaa Zayed, Gamal Esmat, Wafaa Elakel, Hanan Abdel Hafez. Epstein–Barr virus and Interleukin-28B polymorphism in the prediction of response to interferon therapy in hepatitis C patients. Arab Journal of Gastroenterology 2015; 16(3-4): 84 doi: 10.1016/j.ajg.2015.09.013
|
| 15 |
Tonggang Liu, Kaihui Sha, Luhua Yang, Yun Wang, Liguo Zhang, Xianxian Liu, Fang Yang, Wenzhe Ho. IL-28B Polymorphisms Correlated with Treatment Response in HCV-4 Mono-Infected Patients: A Meta-Analysis. PLoS ONE 2014; 9(3): e91316 doi: 10.1371/journal.pone.0091316
|
| 16 |
Noha G Bader El Din, Sally Farouk, Reem El-Shenawy, Marwa K Ibrahim, Reham M Dawood, Mostafa M Elhady, Ahmed M Salem, Naglaa Zayed, Ahmed Khairy, Mostafa K El Awady. Tumor necrosis factor-α -G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients. World Journal of Gastroenterology 2016; 22(34): 7767-7777 doi: 10.3748/wjg.v22.i34.7767
|
| 17 |
Marwa K. Ibrahim, Mohamed AbdElrahman, Noha G. Bader El Din, Salwa Tawfik, Sherief Abd-Elsalam, Dalia Omran, Amal Z. Barakat, Sally Farouk, Hassan Elbatae, Mostafa K. El Awady. The impact of genetic variations in sofosbuvir metabolizing enzymes and innate immunity mediators on treatment outcome in HCV-infected patients. Microbial Pathogenesis 2022; 162: 105311 doi: 10.1016/j.micpath.2021.105311
|
| 18 |
Islam El-Garawani, Sobhy Hassab El-Nabi, Marwa Gadallah, Eman Abdelsameea. Association between IFN-λ 3 Gene Polymorphisms and Outcome of Treatment with Direct Acting Antivirals in Chronic HCV-Infected Egyptian Patients. Immunological Investigations 2021; 50(1): 12 doi: 10.1080/08820139.2020.1722158
|
| 19 |
Fatma Omar Khalil, Ayman Alsebaey, Zeinab Abdelaziz Kasemy, Sabry Moawad Abdelmageed, Hanan Mosaad Bedair, Shimaa Abdelsattar. IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients. Expert Review of Anti-infective Therapy 2022; 20(1): 121 doi: 10.1080/14787210.2021.1935239
|